New diabetes clinical trial: NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)

Published on: May 30, 2019 at 09:30PM
Conditions:   Diabetes type2;   NASH - Nonalcoholic Steatohepatitis;   NAFLD
Intervention:   Biological: "Collection of additional blood tubes; Biobanking (plasma, liver tissue).
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
http://bit.ly/30XSoTB